NewsRx

Search our medical news database

Cancer Vaccine

Vaccines prolong survival of colorectal cancer patients

Published in Vaccine Weekly, May 14th, 2003

by Maria G. Essig, MS, ELS, senior medical writer - A vaccine containing autologous tumor cells and one made with the Newcastle disease virus (NDV) prolonged the survival of patients with colorectal cancer.

"The major treatments of malignant tumors of digestive tract postoperatively are radiotherapy and chemotherapy," said Wei Liang and collaborators at Liaoning Provincal Tumor Research Institute in China. "However, it is very difficult to improve the five-year survival rate. We treated these patients with autologous tumor cell vaccine and NDV vaccine and made a 7-year follow-up survey of postoperative patients with autologous tumor cell vaccine."

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook